Related Experiment Video
Updated: Mar 1, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Acute mechanical circulatory support for cardiogenic shock: the "door to support" time
Michele L Esposito1, Navin K Kapur1
1The Cardiovascular Center, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts, 02339, USA.
Insights
Cardiogenic shock (CS) management requires clear objectives and timely intervention. This review highlights "door to support" time as a key metric and introduces a new CS classification for better treatment selection.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a significant cause of mortality in acute myocardial infarction patients.
- CS presents as a hemodynamic crisis with reduced cardiac output and systemic perfusion.
Purpose of the Study:
- To define key treatment objectives for CS management.
- To introduce "door to support" time as a therapeutic target.
- To present a classification scheme for CS subtypes based on filling pressures.
Main Methods:
- Review of current literature on CS management.
- Discussion of hemodynamic assessment and acute mechanical circulatory support (AMCS) device selection.
- Development of a novel CS classification system.
Main Results:
- Identified four critical treatment objectives for CS.
- Proposed "door to support" time as a crucial metric for improving outcomes.
- Introduced a classification for CS subtypes using cardiac filling pressures.
Conclusions:
- Optimizing CS management necessitates clear treatment goals and timely interventions.
- Early hemodynamic assessment and appropriate AMCS device selection are vital.
- The proposed classification may aid in personalized CS treatment strategies.
Abstract:
Cardiogenic shock (CS) remains a major cause of in-hospital mortality in the setting of acute myocardial infarction. CS begins as a hemodynamic problem with impaired cardiac output leading to reduced systemic perfusion, increased residual volume within the left and right ventricles, and increased cardiac filling pressures. A critical step towards the development of future algorithms is a clear understanding of the treatment objectives for CS. In this review, we introduce the "door to support" time as an emerging target of therapy to improve outcomes associated with CS, define four key treatment objectives in the management of CS, discuss the importance of early hemodynamic assessment and appropriate selection of acute mechanical circulatory support (AMCS) devices for CS, and introduce a classification scheme that identifies subtypes of CS based on cardiac filling pressures.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation I: Adult
Heart Failure V: Medical Management

